Target Name: MUCL1
NCBI ID: G118430
Other Name(s): BS106 | small breast epithelial mucin | Mucin like 1 | Mucin-like protein 1 | Small breast epithelial mucin | Protein BS106 | mucin like 1 | MUCL1_HUMAN | SBEM

MUCL1: A Drug Target / Disease Biomarker

Multiple United States patents have been filed for a protein known as MUCL1 (MuCl1), which has been identified as a potential drug target and biomarker for various diseases, including cancer.

The protein MuCl1, also known as CD90, is a transmembrane protein that is expressed in various tissues throughout the body, including the brain, spleen, heart, and lymphoid organs. It is a member of the immunoglobulin superfamily and is responsible for several functions in the immune system, including regulation of inflammation and immune cell development.

One of the most significant functions of MuCl1 is its role in regulating the development and activation of immune cells. The protein helps to ensure that immune cells are properly stimulated and that they differentiate into functional immune cells that are capable of recognizing and responding to foreign substances in the body.

Another important function of MuCl1 is its role in the regulation of cell death. When cells are no longer needed or are damaged, MuCl1 helps to ensure that they are properly programmed to die and are not allowed to continue to divide and cause harm.

In addition to its functions in immune system regulation, MuCl1 has also been shown to have potential as a drug target and biomarker for various diseases, including cancer.

One of the most promising aspects of MuCl1 as a drug target is its ability to interact with a variety of different proteins, including those that are involved in cancer development. For example, studies have shown that MuCl1 can interact with the protein PDGF-BB, which is involved in the regulation of cell growth and division.

In addition to its potential as a drug target, MuCl1 has also been shown to be a potential biomarker for several diseases, including cancer. For example, studies have shown that levels of MuCl1 have been significantly elevated in the blood and lymphoid organs of cancer patients, and that these levels are associated with the severity of cancer.

In conclusion, MuCl1 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its functions in immune system regulation and cell death regulation make it an attractive target for drug developers, and its potential as a biomarker for cancer makes it an important area of research. Further studies are needed to fully understand the potential of MuCl1 as a drug and biomarker, and to determine its effectiveness in treating various diseases.

Protein Name: Mucin Like 1

Functions: May play a role as marker for the diagnosis of metastatic breast cancer

More Common Targets

MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8 | MYH9 | MYHAS | MYL1 | MYL10 | MYL11 | MYL12A | MYL12B | MYL12BP3 | MYL2 | MYL3 | MYL4 | MYL5 | MYL6 | MYL6B | MYL7 | MYL9 | MYLIP | MYLK | MYLK-AS1 | MYLK-AS2 | MYLK2 | MYLK3 | MYLK4 | MYLKP1 | MYMK | MYMX | MYNN | MYO10 | MYO15A | MYO15B